Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron effect on urethral pressure variations during filling cystometry in women with overactive bladder
NL-OMON46848Active, not recruiting
- Sponsor
- Haaglanden Medical Centre
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of mirabegron in overactive bladder (OAB), sponsored by Haaglanden Medical Centre. Primary endpoint: Reduction in significant urethral pressure variations. Started May 2015; status: active, not recruiting.
02
Drugs
mirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NL-OMON46848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46848.